ATHX Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 Jan 2024 @ 21:58):

Stats
Tagesvolumen	6.46M
Durchschnittsvolumen	1.77M
Marktkapitalisierung	833 204
EPS	$0 ( 2024-03-29 )
Nächstes Ertragsdatum	( $0 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00818
ATR14	$0.00600 (26.55%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-18	Hansen Maia	Sell	67	Common Stock
2023-10-04	Hansen Maia	Sell	23 149	Common Stock
2023-10-04	Camardo Daniel A.	Sell	19 993	Common Stock
2023-09-18	Hansen Maia	Sell	67	Common Stock
2023-08-17	Mayhugh Neema	Buy	27 428	NonQualified Stock Option (right to purchase)

INSIDER POWER
23.17
Last 94 transactions
Buy: 8 476 520 \| Sell: 1 272 175

Volumen Korrelation

Lang: -0.02 (neutral)

Kurz: 0.37 (neutral)

Signal:(49.051) Neutral

Athersys Inc Korrelation

10 Am meisten positiv korreliert
ADN	0.951
INVZ	0.95
ARVL	0.946
ATNF	0.946
KZR	0.944
CAAS	0.943
MPAA	0.94
BPYPN	0.939
PETS	0.939
MMAT	0.939

10 Am meisten negativ korreliert
NVCN	-0.951
STAY	-0.929
TIOA	-0.926
AVEO	-0.924
VCXA	-0.921
XM	-0.92
PCRX	-0.919
BRIVU	-0.919
ITMR	-0.915
ENER	-0.914

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Athersys Inc Korrelation - Währung/Rohstoff

-0.55
( weak negative )

-0.46
( neutral )

0.00
( neutral )

-0.59
( weak negative )

-0.18
( neutral )

0.26
( neutral )

Athersys Inc Finanzdaten

Annual	2022
Umsatz:	$5.33M
Bruttogewinn:	$5.33M (100.00 %)
EPS:	$-5.70

FY	2022
Umsatz:	$5.33M
Bruttogewinn:	$5.33M (100.00 %)
EPS:	$-5.70

FY	2021
Umsatz:	$5 514.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$0

FY	2020
Umsatz:	$1.44M
Bruttogewinn:	$1.44M (100.00 %)
EPS:	$-0.420

Financial Reports:

No articles found.

Athersys Inc

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.